In response, IMAX Corporation reiterated its belief that the transaction is in the best interests of IMAX China shareholders and represents "a compelling offer". According to the company, "While IMAX China's first half results are encouraging reflecting both theatre re-openings and increased box office market share, IMAX China's share price continued to exhibit weakness and its trading volume hit all-time lows throughout 2023 prior to the proposed privatisation transaction despite market awareness of IMAX China's results through weekly box office reporting and the first quarter results released by IMAX Corporation on April 27, 2023. "IMAX China's volume weighted average price for the 30 and 90 full trading days prior to the transaction announcement was $6.46 and $7.50.